Stocks in News
Aarey Drugs & Pharmaceuticals: The company reported higher profit at Rs 2.5 crore in Q1FY22 against Rs 1.35 crore in Q1FY21, revenue increased to Rs 97.51 crore from Rs 25.21 crore YoY.
Fortis Malar Hospitals: The company reported consolidated loss at Rs 1.34 crore in Q1FY22 against loss of Rs 2.91 crore in Q1FY21, revenue rose to Rs 23.18 crore from Rs 9.43 crore YoY.
Nath Bio-Genes (India): The company reported higher profit at Rs 44.91 crore in Q1FY22 against Rs 41.25 crore in Q1FY21, revenue increased to Rs 215.1 crore from Rs 193.64 crore YoY.
Pricol: The company reported consolidated profit at Rs 5.94 crore in Q1FY22 against loss of Rs 30.85 crore in Q1FY21, revenue rose to Rs 319.91 crore from Rs 120 crore YoY.
Gujarat Alkalies and Chemicals: The company reported higher consolidated profit at Rs 63.12 crore in Q1FY22 against Rs 31.81 crore in Q1FY21, revenue increased to Rs 716.44 crore from Rs 469.61 crore YoY.
Ahluwalia Contracts (India): The company reported higher consolidated profit at Rs 34.78 crore in Q1FY22 against Rs 7.47 crore in Q1FY21, revenue jumped to Rs 580.09 crore from Rs 249.84 crore YoY.
No comments:
Post a Comment